Inhalation: Over exposure by inhalation of vapors may
cause respiratory irritation or nonspecific discomfort such as nausea, headache
or weakness.Inhalation of concentrations
above the recommended limits may cause temporary central nervous system
depression with anesthetic effects such as dizziness, headache, incoordination
and loss of consciousness or temporary alteration of the heart’s electrical
activity (cardiac arrhythmia).Gross
overexposure may be fatal.Inhalation
of respirable aerosols of the release agent in this product may cause serious
toxic effect in the lungs, based on animal studies.

Eye: Eye contact with liquid or vapor may cause irritation.

Skin:Skin contact with the
liquid may cause freezing of the skin or irritation.

Skin
Contact: In case of skin contact, wash thoroughly with soap and water.

Ingestion:Ingestion
is unlikely route of exposure.Do not
induce vomiting unless instructed by a physician.

After first aid, get appropriate in-plant,
paramedic, or community medical support.

Note to
Physicians:

Because of
possible disturbance of cardiac rhythm, catecholamine drugs, such as
epinephrine, should be used only in situations of emergency life support.

Section 5
- Fire-Fighting Measures

Fire and Explosion Hazards: Vapors confined in a poorly ventilated
area may be ignited by a spark or flame.Vapors may

travel considerable distances to
source of ignition.Vapors are heavier
than air and may accumulate in low areas.Containers may rupture or explode under fire conditions.Hazardous decomposition products may be
formed.Material can accumulate static
charges, which can cause an incendiary electrical discharge.Empty containers retain product residue and
can be dangerous.

Flammability Classification: Non Flammable aerosol, as determined
by ASTM D 3065-77 and FSHA sec. 1500.45. However, this product contains
components, which may be ignited under certain circumstances.Do not use near sources such as sparks or
open flames.

Fire-Fighting Instructions:Use
dry chemical, foam or CO2; water may be ineffective but should be
used to keep containers cool.

Section 6
- Accidental Release Measures

Spill /Leak
Procedures: Avoid breathing vapors.Evacuate area until vapor has been dispersed.Remove all sources of ignition.Stop or reducedischarge if
it can be done safely.

Section 7
- Handling and Storage

Handling
Precautions: Minimize breathing of vapors and avoid prolonged or repeated
contact with skin.Wear proper
protective equipment.If ventilation is
not sufficient, wear proper respiratory equipment.Do not use near ignition sources.Contents under pressure.Do not puncture or incinerate.

Storage
Requirements: Store in cool dry, well-ventilated area away from all sources
of ignition.Empty container may
contain residues, which are hazardous.Do not store at temperature above 120°F.

Section 8
- Exposure Controls / Personal Protection

Engineering
Controls:

Ventilation:
Provide general or local exhaust ventilation systems to maintain airborne
concentrations below OSHA PELs (Sec. 2). Local exhaust ventilation is
preferred because it prevents contaminant dispersion into the work area by
controlling it at its source.

This product contains the
following chemicals that are subject to release reporting requirements under
section 313 of SARA Title
III.

Chemical
NameCAS
#%
by Weight

Dichlorofluoroethane1717-00-640-50%

Section 16
- Other Information

Prepared
By: Dominick J. Finocchio

The information contained in this MSDS is considered
accurate as of the version date.However, no warranty is expressed or implied regarding the accuracy of
the data.Since the use of this product
is not within the control of Smooth-On Inc., it is the user's obligation to
determine the suitability of the product for its intended application and
assumes all risk and liability for its safe use.